Cargando…

The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease

Parkinson's disease (PD) is the second most common neurodegenerative disorder, affecting 1% of the population over age 60. In those patients cognitive dysfunction is a persistent issue that impairs quality of life and productivity. Neuropathological studies demonstrate significant damage in bra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vazey, Elena M., Aston-Jones, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2012
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404393/ https://www.ncbi.nlm.nih.gov/pubmed/22848194 http://dx.doi.org/10.3389/fnbeh.2012.00048

Ejemplares similares

Precuneus Dysfunction in Parkinson’s Disease With Mild Cognitive Impairment
por: Jia, Xiuqin, et al.
Publicado: (2019)

Rational Pharmacological Approaches for Cognitive Dysfunction and Depression in Parkinson’s Disease
por: Sandoval-Rincón, Maritza, et al.
Publicado: (2015)

Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
por: Novak, Kevin, et al.
Publicado: (2022)

The emerging role of nutrition in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2014)

The Emerging Role of Neuropeptides in Parkinson’s Disease
por: Zheng, Yanan, et al.
Publicado: (2021)

Optimizing Cognitive Training for the Treatment of Cognitive Dysfunction in Parkinson’s Disease: Current Limitations and Future Directions
por: Guglietti, Bianca, et al.
Publicado: (2021)

Slowing of EEG Background Activity in Parkinson’s and Alzheimer’s Disease with Early Cognitive Dysfunction
por: Benz, Nina, et al.
Publicado: (2014)

Emerging Role of Sirtuin 2 in Parkinson’s Disease
por: Liu, Yumei, et al.
Publicado: (2020)

The emerging role of circular RNAs in Parkinson’s disease
por: Liao, Jiajia, et al.
Publicado: (2023)

Norepinephrine: the next therapeutics frontier for Parkinson's disease
por: LeWitt, Peter A
Publicado: (2012)

Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson’s Disease
por: Sala, Gessica, et al.
Publicado: (2016)

The Emerging Role of Circular RNAs in Alzheimer’s Disease and Parkinson’s Disease
por: Zhang, Meng, et al.
Publicado: (2021)

On the Role of Aminochrome in Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Parkinson's Disease
por: Segura-Aguilar, Juan
Publicado: (2019)

Modification of Proteins by Norepinephrine is Important for Vascular Contraction
por: Johnson, Kyle B., et al.
Publicado: (2010)

The Role of L-type Calcium Channels in Olfactory Learning and Its Modulation by Norepinephrine
por: Ghosh, Abhinaba, et al.
Publicado: (2017)

Dysfunction of Cellular Proteostasis in Parkinson’s Disease
por: Lehtonen, Šárka, et al.
Publicado: (2019)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
por: Błaszczyk, Janusz W.
Publicado: (2018)

Sex-dependent noradrenergic modulation of premotor cortex during decision-making
por: Rodberg, Ellen M, et al.
Publicado: (2023)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Executive dysfunction in Parkinson’s disease and timing deficits
por: Parker, Krystal L., et al.
Publicado: (2013)

Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
por: Zou, Li, et al.
Publicado: (2021)

Emerging Treatment Approaches for Parkinson’s Disease
por: Stoker, Thomas B., et al.
Publicado: (2018)

Locus coeruleus-norepinephrine: basic functions and insights into Parkinson’s disease
por: Bari, Bilal Abdul, et al.
Publicado: (2019)

Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease
por: Segura-Aguilar, Juan, et al.
Publicado: (2018)

Brain Mitochondrial Dysfunction in Aging, Neurodegeneration, and Parkinson's Disease
por: Navarro, Ana, et al.
Publicado: (2010)

Editorial: Mitochondria and Endoplasmic Reticulum Dysfunction in Parkinson’s Disease
por: Barodia, Sandeep Kumar, et al.
Publicado: (2019)

Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease
por: Perez-Pardo, Paula, et al.
Publicado: (2017)

Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment
por: Samat, Nor A., et al.
Publicado: (2017)

Deep Brain Stimulation to Alleviate Freezing of Gait and Cognitive Dysfunction in Parkinson's Disease: Update on Current Research and Future Perspectives
por: Huang, Chuyi, et al.
Publicado: (2018)

Noradrenergic Regulation of Central Amygdala in Aversive Pavlovian-to-Instrumental Transfer
por: Campese, Vincent D., et al.
Publicado: (2017)

Functional specificity of the locus coeruleus-norepinephrine system in the attentional networks
por: Ambrosini, Ettore, et al.
Publicado: (2013)

Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish
por: Singh, Chanpreet, et al.
Publicado: (2015)

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
por: Chalermpalanupap, Termpanit, et al.
Publicado: (2013)

The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease
por: Kinghorn, Kerri J., et al.
Publicado: (2017)

Immersive Technology for Cognitive-Motor Training in Parkinson’s Disease
por: Lau, Justin, et al.
Publicado: (2022)

Transcranial Current Stimulation as a Tool of Neuromodulation of Cognitive Functions in Parkinson’s Disease
por: Brak, Ivan V., et al.
Publicado: (2022)

Poorer Cognitive Performance in Patients with Essential Tremor-Parkinson’s Disease vs. Patients with Parkinson’s Disease
por: Louis, Elan D., et al.
Publicado: (2015)

Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
por: Videira, Paula A. Q., et al.
Publicado: (2018)

Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
por: Peterson, Andrew C., et al.
Publicado: (2018)

Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
por: Gao, Xiao-Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vpvnav9fvsmrvjojvf9qlviedr